Protective Effects of Intraventricular Transplanted Human Umbilical Cord-derived Mesenchymal Stem Cells on Hypoxic Ischemic Brain Damages in Rats

FAN Xue, BAI Xiao-Hong, CHEN Juan. et al

Abstract

To determine the therapeutic effect and protective mechanism of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) on newborn rats with hypoxia ischemic brain damage (HIBD). Methods Umbilical cord (3-4 cm) was collected from a healthy male infant for preparation of hUC-MSCs using explants technique. The hUC-MSCs were cultured and labeled with BrdU. The differentiation function of MSCs was identified. Healthy SPF grade neonatal SD rats were randomly divided into sham (n =30), HIBD (n =36) and hUC-MSCs treated HIBD (n =32) groups. BrdU-labeled hUC-MSCs were injected into the right ventricle of the rats in the hUC-MSCs treatment group 24 h after successful induction of HIBD. The growth and development of the rats were recorded. The neurological behavior of the rats were evaluated with Longa score method 3 weeks after hUC-MSCs transplantation. The survival, migration, differentiation and pro-differentiation of the transplanted hUC-MSCs were measured using immunological fluorescence method. Results Rats in the hUC-MSCs treatment group had significant higher weight gain and lower Longa scores (at the second and the third week post transplantation) than those in the HIBD group (P <0.05). BrdU positive cells were found in brain tissues 3 weeks after transplantation, and they were mainly distributed in the damaged hippocampus and cerebral cortex. Three weeks after transplantation, the total signal strength of glial fibrillary acidic protein (GFAP) or neuron-specific enclase (NSE) gradually increased. Conclusion Transplanted hUC-MSCs can migrate brain damages through differentiating into neuron-like cells and promoting endogenous neurological differentiations.

 

Keywords: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs), Hypoxia ischemic brain damage (HIBD), Cellular transplantation therapy, Brain protection effect 

 

Full Text:

PDF


References


LAWN JE, COUSENS S, ZUPAN J, et al. 4 million neonatal deaths; when, where, why. Lancet, 2005, 365 (9462);891-900.

WANG GH, LIU Y, WU XB, et al. Neuroprotective effects of human umbilical cord-derived mesenchymal stromal cells combined with nimodipine against radiation-induced brain injury through inhibition of apoptosis. Cytotherapy, 2016,18 (1): 53-64.

ROSENKRANZ K. KUMBRUCH S, TENBUSCH M, et al. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis. angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell Tissue Res,2012,348(3) :429-438.

XIA G, HONG X. CHEN X, et al. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. Perinat Med,2010,38(2);215-221. RICE JE, 3rd, VANNUCCI RC, BRIERLEY JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol, 1981,9(2) ; 131-141.

DIAOY, MA Q. CUI F, et al. Human umbilical cord esenchymal stem cells; osteogenesis in vivo as seed cells for bone tissue engineering. J Biomed Mater Res, 2009, 91 ( 1 ); 123-131.

ZHOU X, GU J, GU Y. et al. Human umbilical cord- derived mesenchymal stem cells improve learning and memory function in hypoxic-ischemic brain-damaged rats via an IL-8- mediated secretion mechanism rather than differentiation pattern induction. Cell Physiol Biochem, 2015 , 35 ( 6); 2383- 2401.

VASILJEVIC В, M AGL Л JIЛС-DJ UK IС S, GOJNIC M. et al. New insights into the pathogenesis of perinatal hypoxic- ischemic brain injury. Pediatr Int,2011,53(4) :454-462.

PIMENTAL-COELHO PM. MAGALHAES ES, LOPES LMt et al. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage; functional outcome related to neuroprotection in the striatum. Stem Cells Dev,2010, 19(3):351-358.

TOMARG, SRIVASTAVA R. GUPAT N, et al. Human gingival-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun.2010, 393(3):377-383.

ARUTYUNYAN I. ELCHANINOV A, MAKAROV A, et al. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int,2016,2016;6901286 [2016-09-20 ]. https;//www. ncbi. nlm. nib. gov/pmc/ articles/PMC5019943/. doi:10. 1155/2016/6901286.

SOUSA BR, PARREIRA RC, FONSECA EA, et al. Human adult stem cells from diverse origins; an overview from multiparametric immunophenotyping to clinical applications. Cytometry A,2014,85( 1) ;43-77.

HAGBERG H. ICHORD R, PALMER C, et al. Animal models of developmental brain injury: relevance to human disease. A summary of the panel discussion from the Third Hershey Conference on Developmental Cerebral Blood Flow and Metabolism. Dev Neurosci,2002,24(5) :364-366.

Gordon RJ, Mehrabi NF, Maucksch C, et al. Chemokines influence the migration and fate of neural precursor cells from the young adult and middle-aged rat subventricular zone. Exp Neurol, 2012,233 (1); 587-594.

JI G, LIU M, ZHAO XF, et al. NF-кВ signaling is involved in the effects of intranasally engrafted human neural stem cells on neurofunctional improvements in neonatal rat hypoxic-ischemic encephalopathy. CNS Neurosci Ther,2015. 21(12):926-35.

WEI X, DU Z, ZHAO L, et al. IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells, 2009,27( 2); 4 78-488.

NEKANTI U, MOHANTY L, VENUGOPAL P. et al. Optimization and scale-up of wharton ’ s jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res,2010,5(3):244-254.

RYU S, LEE SH, KIM SU, et al. Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain. Neural Regen Res,2016,11(2):298-304.


Refbacks

  • There are currently no refbacks.